These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline. Saiag P; Grob JJ; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Stratigos A; Middelton M; Basholt L; Testori A; Garbe C Eur J Cancer; 2015 Nov; 51(17):2604-8. PubMed ID: 26189684 [TBL] [Abstract][Full Text] [Related]
14. Current and future roles of targeted therapy and immunotherapy in advanced melanoma. Olszanski AJ J Manag Care Spec Pharm; 2014 Apr; 20(4):346-56. PubMed ID: 24684639 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping. Eggermont AM Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171 [TBL] [Abstract][Full Text] [Related]
16. (Neo)adjuvant systemic therapy for melanoma. van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302 [TBL] [Abstract][Full Text] [Related]
17. Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines. Ahmed OA; Kelly C J Laryngol Otol; 2016 May; 130(S2):S133-S141. PubMed ID: 27841141 [TBL] [Abstract][Full Text] [Related]
18. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline. Wright FC; Souter LH; Kellett S; Easson A; Murray C; Toye J; McCready D; Nessim C; Ghazarian D; Hong NJL; Johnson S; Goldstein DP; Petrella T; Curr Oncol; 2019 Aug; 26(4):e541-e550. PubMed ID: 31548823 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment protocols of cutaneous melanoma: latest approach 2010. Petrescu I; Condrea C; Alexandru A; Dumitrescu D; Simion G; Severin E; Albu C; Albu D Chirurgia (Bucur); 2010; 105(5):637-43. PubMed ID: 21141087 [TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF Schadendorf D; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Lesimple T; Plummer R; Schachter J; Dasgupta K; Manson S; Koruth R; Mookerjee B; Kefford R; Dummer R; Kirkwood JM; Long GV Lancet Oncol; 2019 May; 20(5):701-710. PubMed ID: 30928620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]